187 related articles for article (PubMed ID: 25218271)
1. MicroRNA-106b~25 expressions in tumor tissues and plasma of patients with gastric cancers.
Zhang R; Wang W; Li F; Zhang H; Liu J
Med Oncol; 2014 Oct; 31(10):243. PubMed ID: 25218271
[TBL] [Abstract][Full Text] [Related]
2. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.
Imaoka H; Toiyama Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
Gastric Cancer; 2016 Jul; 19(3):744-53. PubMed ID: 26233325
[TBL] [Abstract][Full Text] [Related]
3. Up-Regulation of miR-21, miR-25, miR-93, and miR-106b in Gastric Cancer.
LArki P; Ahadi A; Zare A; Tarighi S; Zaheri M; Souri M; Zali MR; Ghaedi H; Omrani MD
Iran Biomed J; 2018 Nov; 22(6):367-73. PubMed ID: 29859516
[TBL] [Abstract][Full Text] [Related]
4. Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer.
Cai H; Yuan Y; Hao YF; Guo TK; Wei X; Zhang YM
Med Oncol; 2013 Mar; 30(1):452. PubMed ID: 23307259
[TBL] [Abstract][Full Text] [Related]
5. Circulating miR-18a in plasma contributes to cancer detection and monitoring in patients with gastric cancer.
Tsujiura M; Komatsu S; Ichikawa D; Shiozaki A; Konishi H; Takeshita H; Moriumura R; Nagata H; Kawaguchi T; Hirajima S; Arita T; Fujiwara H; Okamoto K; Otsuji E
Gastric Cancer; 2015 Apr; 18(2):271-9. PubMed ID: 24626859
[TBL] [Abstract][Full Text] [Related]
6. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
7. The significance of elevated plasma expression of microRNA 106b~25 clusters in gastric cancer.
Li F; Guo Y; Liu J; Zhang R
PLoS One; 2017; 12(5):e0178427. PubMed ID: 28562634
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNAs in plasma of patients with gastric cancers.
Tsujiura M; Ichikawa D; Komatsu S; Shiozaki A; Takeshita H; Kosuga T; Konishi H; Morimura R; Deguchi K; Fujiwara H; Okamoto K; Otsuji E
Br J Cancer; 2010 Mar; 102(7):1174-9. PubMed ID: 20234369
[TBL] [Abstract][Full Text] [Related]
9. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
[TBL] [Abstract][Full Text] [Related]
10. Effects of microRNA-106 on proliferation of gastric cancer cell through regulating p21 and E2F5.
Yao YL; Wu XY; Wu JH; Gu T; Chen L; Gu JH; Liu Y; Zhang QH
Asian Pac J Cancer Prev; 2013; 14(5):2839-43. PubMed ID: 23803041
[TBL] [Abstract][Full Text] [Related]
11. Plasma miR-940 may serve as a novel biomarker for gastric cancer.
Liu X; Kwong A; Sihoe A; Chu KM
Tumour Biol; 2016 Mar; 37(3):3589-97. PubMed ID: 26456959
[TBL] [Abstract][Full Text] [Related]
12. Exosomal miR-106b serves as a novel marker for lung cancer and promotes cancer metastasis via targeting PTEN.
Sun S; Chen H; Xu C; Zhang Y; Zhang Q; Chen L; Ding Q; Deng Z
Life Sci; 2020 Mar; 244():117297. PubMed ID: 31954745
[TBL] [Abstract][Full Text] [Related]
13. Candidate microRNA biomarkers in human gastric cancer: a systematic review and validation study.
Wang JL; Hu Y; Kong X; Wang ZH; Chen HY; Xu J; Fang JY
PLoS One; 2013; 8(9):e73683. PubMed ID: 24040025
[TBL] [Abstract][Full Text] [Related]
14. Droplet digital PCR-based circulating microRNA detection serve as a promising diagnostic method for gastric cancer.
Zhao G; Jiang T; Liu Y; Huai G; Lan C; Li G; Jia G; Wang K; Yang M
BMC Cancer; 2018 Jun; 18(1):676. PubMed ID: 29929476
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer.
Kong Y; Ning L; Qiu F; Yu Q; Cao B
Cancer Biomark; 2019; 24(4):477-483. PubMed ID: 30909187
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of microRNA 181c expression in gastric cancer tissues and plasma.
Cui MH; Hou XL; Lei XY; Mu FH; Yang GB; Yue L; Fu Y; Yi GX
Asian Pac J Cancer Prev; 2013; 14(5):3063-6. PubMed ID: 23803080
[TBL] [Abstract][Full Text] [Related]
17. [Expression of mir-106b in esophageal squamous cell carcinoma].
Xiao CY; Guo ZJ; Cao L; Ding XW; Liu Q; Wang XC
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Dec; 36(12):1667-1671. PubMed ID: 27998862
[TBL] [Abstract][Full Text] [Related]
18. Circulating microRNA-133, microRNA-17 and microRNA-25 in serum and its potential diagnostic value in gastric cancer.
ZiaSarabi P; Sorayayi S; Hesari A; Ghasemi F
J Cell Biochem; 2019 Aug; 120(8):12376-12381. PubMed ID: 30861177
[TBL] [Abstract][Full Text] [Related]
19. miR-488 acts as a tumor suppressor gene in gastric cancer.
Zhao Y; Lu G; Ke X; Lu X; Wang X; Li H; Ren M; He S
Tumour Biol; 2016 Jul; 37(7):8691-8. PubMed ID: 26738864
[TBL] [Abstract][Full Text] [Related]
20. Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer.
Mu YP; Tang S; Sun WJ; Gao WM; Wang M; Su XL
Asian Pac J Cancer Prev; 2014; 15(20):8893-900. PubMed ID: 25374225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
